Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VINBLASTINE for Brain neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where VINBLASTINE was used for Brain neoplasm.

Most Reported Side Effects for VINBLASTINE

Side Effect Reports % Deaths Hosp.
Off label use 508 9.4% 125 148
Febrile neutropenia 498 9.2% 62 285
Neutropenia 416 7.7% 74 175
Drug ineffective 302 5.6% 68 62
Product use in unapproved indication 265 4.9% 66 73
Disease progression 262 4.9% 58 21
Pyrexia 259 4.8% 26 166
Neuropathy peripheral 258 4.8% 10 32
Nausea 215 4.0% 25 127
Vomiting 172 3.2% 24 105
Malignant neoplasm progression 170 3.2% 45 35
Second primary malignancy 170 3.2% 86 34
Thrombocytopenia 167 3.1% 57 62
Anaemia 165 3.1% 26 58
Hodgkin's disease 165 3.1% 19 48

Other Indications for VINBLASTINE

Hodgkin's disease (2,866) Product used for unknown indication (380) Langerhans' cell histiocytosis (164) Transitional cell carcinoma (116) Bladder cancer (94) Chemotherapy (86) Non-hodgkin's lymphoma (59) Hodgkin's disease nodular sclerosis (54) Lymphoma (54) Diffuse large b-cell lymphoma (52)

Other Drugs Used for Brain neoplasm

TEMOZOLOMIDE (286) BEVACIZUMAB (166) PROCARBAZINE (142) ETOPOSIDE (121) CARBOPLATIN (103) VINCRISTINE (93) CYCLOPHOSPHAMIDE (72) CISPLATIN (67) TRAMETINIB DIMETHYL SULFOXIDE (55) BEVACIZUMAB-AWWB (50)

Related Pages

VINBLASTINE Full Profile All Brain neoplasm Drugs VINBLASTINE Demographics VINBLASTINE Timeline